Cardiovascular Disease and CKD: Core Curriculum 2010

Slides:

Advertisements

Similar presentations

Implementing KDOQI CKD Definition and Staging Guidelines in Southern California Kaiser Permanente Mark Rutkowski, MD, Wendy Mann, PharmD, Stephen Derose,

Advertisements

Fredrik Karlsson, MD, Angelo Modica, MD, Thomas Mooe, MD, PhD

Urine Potassium Excretion, Kidney Failure, and Mortality in CKD

Impact of the Triglycerides to High-Density Lipoprotein Cholesterol Ratio on the Incidence and Progression of CKD: A Longitudinal Study in a Large Japanese.

Chronic Kidney Disease in Diabetes

Copyright © 2015 by the American Osteopathic Association.

Hazard ratio (HR) for mortality for a 1-kg/m2 increase in body mass index (BMI) across the range of baseline BMI among patients with acute ischemic stroke.

Cystatin C and Albuminuria as Risk Factors for Development of CKD Stage 3: The Multi- Ethnic Study of Atherosclerosis (MESA) Shani Shastri, MD, MS, Ronit.

Uric Acid and Long-term Outcomes in CKD

KDOQI US Commentary on the 2013 KDIGO Clinical Practice Guideline for Lipid Management in CKD Mark J. Sarnak, MD, MS, Roy Bloom, MD, Paul Muntner, PhD,

Chapter 2: Pharmacological cholesterol-lowering treatment in adults

Shoshana H. Ballew, PhD, Yan Chen, BS, Natalie R. Daya, MPH, Job G

Peritoneal dialysis American Journal of Kidney Diseases

Estimating GFR Using the CKD Epidemiology Collaboration (CKD-EPI) Creatinine Equation: More Accurate GFR Estimates, Lower CKD Prevalence Estimates, and.

Olivier Niel, MD, PhD, Charlotte Boussard, MSc, Paul Bastard, MSc

Metabolic Complications in Elderly Adults With CKD

Development of Reduced Kidney Function in Rheumatoid Arthritis

Francesca Mallamaci, MD, Giovanni Tripepi, PhD

Volume 93, Issue 4, Pages (April 2018)

A Decade After the KDOQI CKD Guidelines

Blood Lead Levels and Decreased Kidney Function in a Population-Based Cohort Florencia Harari, Gerd Sallsten, Anders Christensson, Marinka Petkovic, Bo.

Risk of Venous Thromboembolism in Patients by Albuminuria and Estimated GFR David Massicotte-Azarniouch, MD, Anan Bader Eddeen, MSc, Alejandro LazoLanger,

Chronic Kidney Disease in Diabetes

Recognition for Conservative Care in Kidney Failure

Blood Lead Levels and Decreased Kidney Function in a Population-Based Cohort Florencia Harari, Gerd Sallsten, Anders Christensson, Marinka Petkovic, Bo.

A New Clinical Prediction Tool for 5-Year Kidney Transplant Outcome

Differences in Use of Peritoneal Dialysis and Survival Among East Asian, Indo Asian, and White ESRD Patients in Canada Brenda R. Hemmelgarn, PhD, MD,

Your Kidneys May Outlive You

Focusing on Health Literacy Might Help Us Cross the Quality Chasm

Daniel E. Weiner, MD, MS American Journal of Kidney Diseases

Erratum American Journal of Kidney Diseases

Molly E. Waring, PhD, Jane S

Guidelines for the Older Adult With CKD

Lifetime Incidence of CKD Stages 3-5 in the United States

Baseline Kidney Function as Predictor of Mortality and Kidney Disease Progression in HIV-Positive Patients Fowzia Ibrahim, MSc, Lisa Hamzah, MRCP, Rachael.

The Kidney Early Evaluation Program (KEEP): Program Design and Demographic Characteristics of the Population Claudine T. Jurkovitz, MD, MPH, Yang Qiu,

Joseph A. Vassalotti, MD, Lesley A. Stevens, MD, MS, Andrew S

Navdeep Tangri, MD, FRCPC, Daniel E. Weiner, MD, MS

Management of Heart Failure in Advancing CKD: Core Curriculum 2018

David C. Mendelssohn, MD, FRCPC, Jay B. Wish, MD

On Statin Treatment to Prevent Sepsis in Dialysis Patients

GFR Decline and Subsequent Risk of Established Kidney Outcomes: A Meta-analysis of 37 Randomized Controlled Trials Hiddo J. Lambers Heerspink, PhD, Hocine.

CKD and the Risk of Acute, Community-Acquired Infections Among Older People With Diabetes Mellitus: A Retrospective Cohort Study Using Electronic Health.

Socioeconomic Status and Reduced Kidney Function in the Whitehall II Study: Role of Obesity and Metabolic Syndrome Talal M. Al-Qaoud, MD, MSc, Dorothea.

A Decade After the KDOQI CKD Guidelines: A Perspective From Mexico

Michael F. Flessner, MD, PhD, Sharon B. Wyatt, PhD, Ermeg L

Beef Tea, Vitality, Creatinine, and the Estimated GFR

Evidence and Outcomes in CKD

Drug Dose Adjustments in Patients With Renal Impairment

Daniel E. Weiner, MD, MS, Mark J. Sarnak, MD, MS

Methods for guideline development

Michael J. Germain, MD, Sara N. Davison, MD, Alvin H. Moss, MD

Volume 85, Issue 5, Pages (May 2014)

Long-term Outcomes of Acute Kidney Injury: The Power and Pitfalls of Observational/Population-Based Studies Charuhas V. Thakar, MD American Journal.

Lesley A. Stevens, MD, MS, Josef Coresh, MD, PhD, Andrew S. Levey, MD

Volume 80, Issue 12, Pages (December 2011)

Hypertension and CKD: Kidney Early Evaluation Program (KEEP) and National Health and Nutrition Examination Survey (NHANES), Madhav V. Rao,

August Heidland, MD, Udo Bahner, MD, Spiros Vamvakas, MD

In the Literature: Cognitive Impairment in Hemodialysis Patients

Achieving Fairness in Access to Kidney Transplant: A Work in Progress

Cardiovascular risk in chronic kidney disease

Patient Safety Issues in CKD: Core Curriculum 2015

Shoshana H. Ballew, PhD, Yan Chen, BS, Natalie R. Daya, MPH, Job G

Ann M. O'Hare, MA, MD American Journal of Kidney Diseases

Dialysis Research and N-of-1 Trials: Made for Each Other?

Clinical Practice Recommendations For Peritoneal Dialysis Adequacy

National Kidney Foundation's Kidney Early Evaluation Program (KEEP) Annual Data Report 2009: Executive Summary Peter A. McCullough, MD, MPH, Joseph A.

Clinical Practice Guidelines for Peritoneal Dialysis Adequacy

Medication Adherence Behavior and Priorities Among Older Adults With CKD: A Semistructured Interview Study Dena E. Rifkin, MD, MS, M. Barton Laws, PhD,

Jacob J.E. Koopman, MD, PhD American Journal of Kidney Diseases

Presentation transcript:

Cardiovascular Disease and CKD: Core Curriculum 2010 Shani Shastri, MD, Mark J. Sarnak, MD, MS American Journal of Kidney Diseases Volume 56, Issue 2, Pages 399-417 (August 2010) DOI: 10.1053/j.ajkd.2010.03.019 Copyright © 2010 National Kidney Foundation, Inc. Terms and Conditions

Figure 1 Hazard ratios for cardiovascular events according to baseline estimated glomerular filtration rate (eGFR), adjusted for baseline age, sex, income, education, coronary disease, chronic heart failure, stroke or transient ischemic attack, peripheral artery disease, diabetes, hypertension, dyslipidemia, cancer, hypoalbuminemia, dementia, liver disease, proteinuria, prior hospitalizations, and subsequent dialysis requirement. Plotted using data from Go et al (N Engl J Med. 2004;351(13):1296-1305). American Journal of Kidney Diseases 2010 56, 399-417DOI: (10.1053/j.ajkd.2010.03.019) Copyright © 2010 National Kidney Foundation, Inc. Terms and Conditions